GlaxoSmithKline (GSK) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 2, 2023 (14:08)
Sector: HealthcareThe share price of GlaxoSmithKline plc (GSK) now
50/200 Day Moving Average: $35.92 / $35.5
This figure corresponds to the Average Price over the previous 50/200 days. For GlaxoSmithKline stocks, the 50-day moving average is the support level today.
For GlaxoSmithKline stocks, the 200-day moving average is the support level today.
Are you interested in GlaxoSmithKline plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the GlaxoSmithKline stock price in 2023, 2024, 2025, 2026, 2027. How much will one GlaxoSmithKline share be worth in 2023 - 2027?
When should I take profit in GlaxoSmithKline stock? When should I record a loss on GlaxoSmithKline stock? What are analysts' forecasts for GlaxoSmithKline stock? What is the future of GlaxoSmithKline stock? We forecast GlaxoSmithKline stock performance using neural networks based on historical data on GlaxoSmithKline stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
GlaxoSmithKline stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for GlaxoSmithKline shares. This happens once a day.
Historical and forecast chart of GlaxoSmithKline stock
The chart below shows the historical price of GlaxoSmithKline stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GlaxoSmithKline stock price can be found in the table below.
Long-term forecasts by years.
GlaxoSmithKline plc is engaged in the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines, OTC drugs and health-related consumer products in the United Kingdom, the United States and internationally. It operates in four segments: pharmaceuticals, pharmaceutical research and development, vaccines and consumer healthcare. The company offers pharmaceutical products that include drugs in therapeutic areas such as respiratory, HIV, immunoinflammatory, cancer, antiviral, central nervous system, cardiovascular and urogenital, metabolic, antibacterial and dermatological. It also provides consumer healthcare products in the categories of health, oral health, nutrition, and skin health. The company offers its consumers medical products in the form of nasal sprays, tablets, syrups, lozenges, chewing gums and transdermal patches, drops, drops of baby syrup, liquid suspension, wipes, gels, effervescent substances, toothpastes, toothbrushes, mouth rinses, adhesives for dentures and detergents, topical creams and non-drug plasters, lip balms, chewing gums and soft chewing gums. She has cooperation agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics specializing in immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, UK.
GlaxoSmithKline daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 04 | 37.06 | 36.75 | 37.33 | 1.56 |
| Dec 05 | 36.97 | 36.62 | 37.25 | 1.72 |
| Dec 06 | 36.80 | 36.67 | 37.15 | 1.29 |
| Dec 07 | 36.60 | 36.46 | 36.73 | 0.76 |
| Dec 08 | 36.73 | 36.61 | 37.05 | 1.20 |
| Dec 09 | 36.89 | 36.69 | 37.20 | 1.40 |
| Dec 10 | 36.86 | 36.61 | 37.02 | 1.12 |
| Dec 11 | 36.78 | 36.45 | 37.10 | 1.79 |
| Dec 12 | 36.52 | 36.41 | 36.63 | 0.59 |
| Dec 13 | 36.53 | 36.28 | 36.79 | 1.40 |
| Dec 14 | 36.10 | 35.97 | 36.30 | 0.92 |
| Dec 15 | 36.15 | 35.85 | 36.27 | 1.17 |
| Dec 16 | 36.19 | 36.08 | 36.52 | 1.22 |
| Dec 17 | 36.11 | 35.84 | 36.33 | 1.37 |
| Dec 18 | 36.49 | 36.16 | 36.71 | 1.51 |
| Dec 19 | 36.48 | 36.13 | 36.71 | 1.61 |
| Dec 20 | 36.57 | 36.42 | 36.77 | 0.95 |
| Dec 21 | 36.64 | 36.37 | 36.93 | 1.55 |
| Dec 22 | 36.79 | 36.55 | 37.03 | 1.30 |
| Dec 23 | 37.01 | 36.82 | 37.28 | 1.24 |
| Dec 24 | 36.97 | 36.69 | 37.10 | 1.12 |
| Dec 25 | 36.72 | 36.57 | 36.96 | 1.07 |
| Dec 26 | 36.78 | 36.62 | 37.03 | 1.11 |
| Dec 27 | 37.13 | 36.96 | 37.44 | 1.30 |
| Dec 28 | 37.10 | 36.99 | 37.33 | 0.93 |
| Dec 29 | 37.49 | 37.17 | 37.60 | 1.16 |
| Dec 30 | 37.65 | 37.38 | 37.81 | 1.14 |
| Dec 31 | 37.60 | 37.44 | 37.86 | 1.11 |
| Jan 01 | 37.59 | 37.44 | 37.74 | 0.81 |
| Jan 02 | 37.81 | 37.59 | 38.11 | 1.36 |
GlaxoSmithKline Daily Price Targets
GlaxoSmithKline Stock Forecast 12-04-2023.
Forecast target price for 12-04-2023: $37.06.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.537%.
Pessimistic target level: 36.75
Optimistic target level: 37.33
GlaxoSmithKline Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $36.97.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.691%.
Pessimistic target level: 36.62
Optimistic target level: 37.25
GlaxoSmithKline Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $36.80.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.272%.
Pessimistic target level: 36.67
Optimistic target level: 37.15
GlaxoSmithKline Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $36.60.
Negative dynamics for GlaxoSmithKline shares will prevail with possible volatility of 0.753%.
Pessimistic target level: 36.46
Optimistic target level: 36.73
GlaxoSmithKline Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $36.73.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.190%.
Pessimistic target level: 36.61
Optimistic target level: 37.05
GlaxoSmithKline Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $36.89.
Positive dynamics for GlaxoSmithKline shares will prevail with possible volatility of 1.380%.
Pessimistic target level: 36.69
Optimistic target level: 37.20
GSK (GSK) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec. | 35.97 | 35.24 | 37.03 | 4.81 |
GlaxoSmithKline forecast for this year
GlaxoSmithKline Stock Prediction for Dec 2023
An downtrend is forecast for this month with an optimal target price of $35.9736. Pessimistic: $35.24. Optimistic: $37.03
GlaxoSmithKline (GSK) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 36.31 | 35.21 | 36.82 | 4.38 |
| Feb | 36.49 | 35.58 | 37.13 | 4.18 |
| Mar | 36.37 | 35.63 | 37.10 | 3.98 |
| Apr | 36.49 | 35.48 | 37.13 | 4.45 |
| May | 36.11 | 35.74 | 36.76 | 2.76 |
| Jun | 36.35 | 35.27 | 37.27 | 5.36 |
| Jul | 36.66 | 36.10 | 37.43 | 3.55 |
| Aug | 37.05 | 36.17 | 38.00 | 4.83 |
| Sep | 36.40 | 35.57 | 36.85 | 3.47 |
| Oct | 36.82 | 35.67 | 37.35 | 4.50 |
| Nov | 36.26 | 35.57 | 36.81 | 3.38 |
| Dec | 36.23 | 35.41 | 37.20 | 4.79 |
GlaxoSmithKline (GSK) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 36.77 | 36.37 | 37.29 | 2.46 |
| Mar | 36.54 | 35.87 | 36.86 | 2.67 |
| Mar | 36.53 | 35.39 | 37.30 | 5.12 |
| Apr | 37.62 | 36.96 | 38.11 | 3.00 |
| May | 38.42 | 37.83 | 38.97 | 2.92 |
| Jun | 38.69 | 37.87 | 39.77 | 4.78 |
| Jul | 37.90 | 37.44 | 38.48 | 2.69 |
| Aug | 38.52 | 38.00 | 39.39 | 3.55 |
| Sep | 38.97 | 37.94 | 39.95 | 5.02 |
| Oct | 37.89 | 37.36 | 38.29 | 2.43 |
| Nov | 38.80 | 37.99 | 39.67 | 4.23 |
| Dec | 38.95 | 37.84 | 39.80 | 4.92 |
GlaxoSmithKline (GSK) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 39.90 | 39.17 | 41.09 | 4.66 |
| Mar | 40.37 | 39.58 | 41.10 | 3.68 |
| Mar | 40.97 | 40.27 | 41.93 | 3.96 |
| Apr | 40.54 | 39.89 | 41.69 | 4.32 |
| May | 39.72 | 39.22 | 40.89 | 4.09 |
| Jun | 39.86 | 38.94 | 41.02 | 5.08 |
| Jul | 39.86 | 39.26 | 40.80 | 3.77 |
| Aug | 41.32 | 40.11 | 41.85 | 4.16 |
| Sep | 42.54 | 42.04 | 43.57 | 3.50 |
| Oct | 42.52 | 41.46 | 43.77 | 5.27 |
| Nov | 43.82 | 43.34 | 44.81 | 3.28 |
| Dec | 45.30 | 44.69 | 46.52 | 3.95 |
GlaxoSmithKline (GSK) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 45.41 | 44.97 | 46.40 | 3.09 |
| Mar | 45.55 | 44.22 | 46.41 | 4.71 |
| Mar | 45.50 | 44.08 | 46.33 | 4.86 |
| Apr | 44.38 | 43.17 | 45.75 | 5.64 |
| May | 44.71 | 44.12 | 45.93 | 3.95 |
| Jun | 44.13 | 43.14 | 44.77 | 3.65 |
| Jul | 45.79 | 45.14 | 46.34 | 2.58 |
| Aug | 46.29 | 44.99 | 47.73 | 5.75 |
| Sep | 46.90 | 46.13 | 48.18 | 4.25 |
| Oct | 48.22 | 46.79 | 49.46 | 5.40 |
| Nov | 48.65 | 47.17 | 49.16 | 4.05 |
| Dec | 49.96 | 48.73 | 51.07 | 4.58 |
GlaxoSmithKline information and performance
980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB
Market capitalization of the GlaxoSmithKline plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GSK shares in the company outstanding by the market price of one share.
EBITDA of GlaxoSmithKline is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
GlaxoSmithKline (GSK) stock dividend
GlaxoSmithKline last paid dividends on 08/17/2023. The next scheduled payment will be on 01/11/2024. The amount of dividends is $0.558 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
